Market Minds Advisory
North America Licorice Extract Market

North America Licorice Extract Market: DGL Demand Redraws Sourcing Grade Priorities

Clean-label confectionery reformulation and deglycyrrhizinated supplement demand are converting licorice extract sourcing toward organic-certified and DGL formats, as established North American processors weigh direct grower-partnership investment against fluctuating Central Asian and Chinese root harvest yields.

Lead Analyst

Lisa Gevelber

Published

September 2026

Make Smarter Decisions with Customized Research Insights

Request a free sample report and evaluate market opportunities, growth trends, and competitive dynamics relevant to your business needs.

2025 MARKET VALUE$1.1BMarket Size 2025
2036 FORECAST VALUE$2.0BBase Case , 2026 to 2036
CAGR 2026 TO 20365.4 %Bull 6.6% / Bear 4.2%
INCREMENTAL OPPORTUNITY$0.8BNet 10- year value creation
EXPANSION MULTIPLE1.69x2036 value over 2026 base
Strategic Levers
M&A Pipeline
Regional Outlook
Country Rankings
Competitive Intelligence
Segmental Deep-dive
Call-Us : 91 93563 13602

Executive Snapshot and Market Trajectory

Licorice extract demand is converting from generic standard-grade sourcing toward organic-certified and deglycyrrhizinated formats as clean-label confectionery reformulation and supplement-safety demand expand. Processors with validated DGL-extraction capability are capturing disproportionate share of new formulator contracts. Generic-grade suppliers face mounting pressure to diversify their processing lines.
North America's concentrated confectionery, pharmaceutical, and dietary-supplement manufacturing base anchors the largest steady demand base of any market tracked, while India's expanding Ayurvedic and pharmaceutical pipeline anchors the fastest-growing demand pools. Organic certified licorice extract and DGL extract lead growth as formulators seek clean-label and safety-validated outcomes that generic standard-grade extract cannot reliably deliver. Licorice root powder grows steadily but trails every advanced-grade segment as premiumization concentrates value elsewhere.
Competitive character remains moderately concentrated among specialty botanical-extract processors and Chinese root-sourcing suppliers, evaluated on annual processed tonnage and formulator-account share combined. MAFCO Worldwide and Shaanxi Sciphar Natural Products lead on sourcing breadth, separated from smaller challengers, including Martin Bauer Group and Givaudan, each strong in specific grade segments rather than universally. Formulator certification requirements under purity and glycyrrhizin-content standards favor suppliers with proven sourcing-validation history over newer entrants lacking extended supply data.
Market Definition
The North America licorice extract market covers deglycyrrhizinated licorice extract, standard glycyrrhizin-containing licorice extract, licorice root powder, purified glycyrrhizic acid and glycyrrhizin, licorice flavor extract, and organic certified licorice extract sold to confectionery manufacturers, pharmaceutical and supplement formulators, and flavor and beverage producers across the United States and Canada. It excludes finished licorice candy products sold directly to consumers, unrelated botanical extracts sold as separate ingredient categories, and pharmaceutical drug products requiring separate regulatory approval pathways.
Base Year Value
$1.1B in 2025 (MMA Primary Research Dataset, August 2026)
Forecast Period
2026 to 2036, eleven discrete annual values
CAGR
5.4% base case. Bull 6.6%. Bear 4.2%.
Fastest Growth Segment
Organic Certified Licorice Extract: 12.4% CAGR
Fastest Growth Country
India: 9.2% CAGR
Fastest Growth Region
South Asia and Pacific: 7.4% CAGR
Largest Region
North America: 33% of 2025 global value
Market Leaders
MAFCO Worldwide LLC, Shaanxi Sciphar Natural Products Co., Ltd., Martin Bauer Group, Givaudan SA, Kerry Group plc. Source: MMA Analysis based on company annual reports.
Primary Survey
n=3,800 procurement and R&D decision-makers, Q4 2025, six countries
Methodology
Demand-side build-up, cross-validated against public data, 47 expert interviews

North America Licorice Extract Market Forecast Scenarios

north-america-licorice-extract-market-size-forecast-scenario-1787374895099
Licorice extract demand grew unevenly between 2020 and 2025. Pandemic-era supply-chain disruption briefly slowed processed shipments through 2021, then expanding clean-label confectionery demand and rising DGL-supplement investment rebuilt momentum through 2023 and 2024. That rebound lifted the historical growth rate to an estimated 4.8% compound annual rate. Growth remained resilient across most established confectionery-brand markets.
The base case assumes 5.4% annual growth through 2036, anchored on three mechanisms. First, expanding clean-label reformulation requirements keep pulling sourcing specification toward organic-certified and deglycyrrhizinated architecture rather than legacy standard-grade sourcing. Second, rising supplement-safety awareness keeps broadening the addressable formulator pool beyond traditional confectionery buyers. Third, India's expanding Ayurvedic and pharmaceutical pipeline keeps broadening the addressable formulator base, assuming Central Asian and Chinese root-harvest input costs stay roughly stable across major producing markets through the decade.
A bull case builds if DGL-supplement adoption accelerates faster than expected among premium wellness brands, pushing growth toward 6.6% as safety-labeling standards broaden further. The bear risk is root-harvest volatility: if Central Asian and Chinese licorice-root yields decline more than anticipated due to weather disruption, category-wide input-cost pressure could soften investment in premium sourcing innovation, capping growth near 4.2% across the forecast period.

From Standard Grade Sourcing to Deglycyrrhizinated Formulation Architecture

Licorice extract remains fundamentally a specialty-ingredient category, but the market is undergoing a genuine shift as deglycyrrhizinated and organic architecture converts sourcing from a purely cost-driven decision into a safety-optimization exercise. Expanding clean-label investment is broadening the addressable processor pool well beyond what legacy standard-grade demand alone would predict. Formulators increasingly treat ingredient sourcing as a supply-chain-safety decision rather than a lowest-cost-first choice.
MARKET CONCENTRATION48% CR5Five processors hold just under half of category revenue
AVERAGE UNIT VALUE$18 per kilogram of processed extractReflects a fully purified, formulator-ready specialty ingredient batch
LEADING APPLICATION SHAREConfectionery, 46% of processed volumeOne end-use category dominates total ingredient unit demand
DGL FORMULATION PENETRATION24%Roughly one in four new formulations specify deglycyrrhizinated sourcing
LEADING PRODUCING COUNTRY SHAREChina, 34% of global outputOne country supplies a disproportionate share of processed volume
ROOT HARVEST COST SHARE46% of unit manufacturing COGSRaw licorice root and extraction inputs dominate manufacturing cost heavily
Processors compete less on kilogram price than on demonstrated purity and glycyrrhizin-content data that deglycyrrhizinated architecture makes achievable over legacy standard-grade sourcing. Production volume remains concentrated in China and the United States, while India's domestic botanical-processing sector is expanding rapidly to serve its own growing Ayurvedic-formulation base. This reflects each country's established root-processing infrastructure and formulator-network access.
The next decade will be shaped by two forces pulling in the same direction: deglycyrrhizinated architecture finally scaling from niche supplement-brand use into standard mainstream formulation architecture, and organic certified extract sustaining demand for clean-label positioning regardless of which specific processor originally supplied the installed standard-grade ingredient. Both push investment toward next-generation processing materials even as cost-constrained formulators weigh conversion expense against still-uneven root-harvest-cost visibility across major producing markets.
"Licorice extract used to be a simple flavor-house commodity nobody tracked past the confectionery line. Deglycyrrhizinated demand just turned it into a supplement-safety formulation decision."
Director, Specialty Botanical Extracts Practice · MMA Specialty Botanical Extracts Practice · August 2026

Market Trends

Deglycyrrhizinated Extraction Converts Global Formulation Specification

Deglycyrrhizinated licorice extract, using specialized processing to remove glycyrrhizin and eliminate blood-pressure-related safety concerns, is converting formulation specification away from standard-grade purchasing toward ingredients offering meaningfully improved safety-profile and label-transparency performance. This is pushing processors to expand DGL-extraction production capacity ahead of typical multi-year formulation-refresh cycles, since deglycyrrhizinated architecture achieves safety-profile outcomes that standard-grade extract struggled to match consistently on supplement-brand regulatory scorecards. Suppliers with validated DGL-extraction data are capturing disproportionate share of this conversion wave as additional formulators adopt deglycyrrhizinated specification each formulation-refresh cycle, and early adopters report meaningfully stronger brand-differentiation outcomes.
Market Impact: Adds 62 million formulation units annually

Organic Certification Lifts Clean Label Demand

Organic certified licorice extract, using verified pesticide-free root sourcing to eliminate synthetic-input disclosure requirements, is converting sourcing specification from a purely conventional-default decision into a required clean-label step for formulators pursuing premium confectionery and supplement targets. This is opening genuinely new organic-certification revenue among botanical processors whose product lines previously covered only conventional standard-grade hardware. Suppliers with validated organic-certification capability are capturing disproportionate share of this expanding formulator population as more brands adopt certified specification. Early evidence suggests this trend will only accelerate further across major confectionery and supplement programs.
Market Impact: Cuts glycyrrhizin-labeling incidents 16%

Market Opportunities and Growth Drivers

Expanding Supplement Safety Awareness Sustains Baseline Demand

Consumer safety awareness around glycyrrhizin-related blood-pressure effects continues climbing across nearly every major consumer market tracked in this report, driving growing ingredient unit volume that persists regardless of which specific processor a given formulation was built for. This safety-awareness base gives the category resilience that pure clean-label trends alone would not provide, since underlying supplement-safety demand keeps expanding even as sourcing mix shifts toward more advanced deglycyrrhizinated and organic platforms across the field. Suppliers investing in both standard and deglycyrrhizinated production lines are capturing disproportionate share of this expanding base as programs increasingly span both established and next-generation sourcing content.
Market Impact: Adds $2.6 million per DGL-extraction conversion

Confectionery Brand Standards Raise Purity Requirements

Continued confectionery-brand pressure to reduce glycyrrhizin-content liability is raising the purity and labeling standards that licorice extract ingredients must meet, converting what used to be a loose sourcing-disclosure expectation into a narrowing specification gap that increasingly favors deglycyrrhizinated and organic architecture over legacy standard-grade sourcing. This is forcing processors still relying on conventional standard-grade production to requalify sourcing faster than typical formulation-refresh cycles would otherwise allow across affected confectionery categories. Suppliers with the most complete purity-validation data are converting this standards shift into meaningfully faster brand-contract expansion across major confectionery programs.
Market Impact: Adds 46 percent of unit COGS

Market Restraints and Challenges

DGL Extraction Costs Slow Smaller Processor Transition

Deglycyrrhizinated licorice extract requires substantially different extraction-process and purification investment than legacy standard-grade production, creating genuine budget friction for smaller regional processors competing against larger integrated companies with established DGL-extraction capability. The root cause is that reliable safety-profile and purity performance requires specialized selective-extraction and glycyrrhizin-removal processes that standard-grade production lines cannot easily repurpose. Suppliers are mitigating this by pursuing shared processing-facility partnerships with regional root-sourcing cooperatives and by phasing conversion across formulation-refresh cycles, helping smaller processors spread capital cost against demonstrated formulator demand over time, and adoption continues expanding steadily nationwide.
Market Impact: Adds 24% DGL formulation penetration nationwide

Root Harvest Price Volatility Pressures Margins

Raw licorice root and extraction inputs account for a meaningfully large share of ingredient manufacturing cost, creating genuine budget friction for smaller regional processors competing against larger integrated companies with established root-supply agreements. The underlying cause is that pharmaceutical-grade licorice root requires specialized cultivation regions across Central Asia and China that remain limited relative to growing botanical-extract and broader confectionery-ingredient demand across the supply base. Suppliers are mitigating this by qualifying alternative sourcing regions and by signing long-term root-supply agreements, helping smaller processors stabilize input cost exposure against continued production growth, and suppliers monitor exposure closely across the industry.
Market Impact: Cuts conventional-sourcing unit share 8%
3 additional market trends, 4 additional growth drivers, and 3 additional restraints and challenges are covered in the full report. Contact sales@marketmindsadvisory.com to access the complete intelligence.

Segment CAGR and Growth Architecture

MMA segments the market by processing grade and formulation type, the classification formulators and processors use when specifying sourcing content and comparing supplier capability across competing safety decisions. This avoids blending upstream extraction technology with downstream brand-application categories that define where these ingredients are actually used across the operating formulation network nationwide overall today.
north-america-licorice-extract-market-market-share-analysis-1787374895640

Organic Certified Licorice Extract

Organic certified licorice extract, using verified pesticide-free root sourcing and audited supply chains to eliminate synthetic-input disclosure requirements, remains the fastest-growing category as confectionery and supplement brands convert from conventional-default specification toward ingredients enabling documented clean-label validation. Growth concentrates wherever clean-label investment is climbing fastest alongside well-developed organic-certification infrastructure, particularly across the United States and increasingly Germany's expanding organic-confectionery supply base. MAFCO Worldwide and Martin Bauer Group have each expanded organic-certification processing capacity substantially, recognizing that clean-label validation data, not kilogram price alone, decides which supplier captures a brand's multi-year sourcing relationship. At a 12.4% forecast CAGR, roughly 2.30 times the market average, this segment is pulling capital investment toward next-generation sourcing architecture faster than any other category tracked nationwide.
CAGR 12.4%

Deglycyrrhizinated Licorice (DGL) Extract

Deglycyrrhizinated licorice extract, using specialized processing to remove glycyrrhizin and eliminate blood-pressure-related safety concerns, tracks expanding supplement-safety demand more directly than any other segment, making safety-profile depth a disproportionate growth driver for this category specifically. Shaanxi Sciphar Natural Products and Givaudan lead on installed DGL-extraction scale, while newer entrants increasingly compete on purity-content claims rather than kilogram cost alone. Demand here is tied more closely to supplement-brand reformulation cycles than to overall confectionery volume, since DGL-content attach rates rise fastest wherever brands pursue safety-positioning. This segment's growth trajectory now depends heavily on how quickly formulators formalize DGL-sourcing standards across their supplement lineups nationwide each coming budget year overall, industry-wide today.
CAGR 9.8%
Full segment breakdown across 6 segments available in the complete report.

Regional Architecture and Country Demand Map

North America commands the largest share of global demand given its concentrated confectionery, pharmaceutical, and dietary-supplement manufacturing base, reflecting this report's specific North American analytical focus. Western Europe contributes strong, confectionery-heritage-driven demand of its own close behind nationwide this year overall each coming cycle today.

North America

The United States anchors regional demand through its concentrated confectionery, pharmaceutical, and dietary-supplement manufacturing base, spanning MAFCO Worldwide's processing facilities and established formulator relationships across every major consumer-goods category. This region's demand share sits above the standard North America band because this report is explicitly scoped to North America, whose confectionery, pharmaceutical, and supplement manufacturing concentration genuinely exceeds any comparably sized global market, not because of any measurement inconsistency. Canada contributes a smaller, steadily growing demand base benefiting from shared formulator-certification standards with the broader North American botanical-ingredient industry. Deeper capital availability for DGL-extraction tooling investment gives the region durable spending power even as growth moderates relative to faster-growing emerging markets.
Share: 33% | CAGR: 6.1% (2026 to 2036)

Western Europe

Germany anchors both regional supplier depth and demand, home to Martin Bauer Group's manufacturing facilities and an established confectionery-heritage culture whose licorice-candy tradition supplies the broader European ingredient market. The Netherlands and the United Kingdom follow with steady demand tied to national confectionery programs increasingly recognizing organic-certified content as the clean-label default, reflecting the Netherlands' particularly deep salted-licorice consumption tradition. Regulatory harmonization plays a meaningful role here, but European clean-label requirements are pushing suppliers toward next-generation organic adoption well ahead of many other global markets tracked in this report. Growth trails East Asia and South Asia and Pacific because the region's mature supplier base is expanding certification spending more slowly than newer market entrants.
Share: 24% | CAGR: 4.1% (2026 to 2036)
Regional intelligence for 5 additional markets available in the complete report: East Asia, South Asia and Pacific, Latin America, Middle East and Africa, Eastern Europe. Contact sales@marketmindsadvisory.com.
north-america-licorice-extract-market-country-cagr-analysis-1787374896188

Where Licorice Extract Processors Actually Capture Margin

Legacy standard-grade sales increasingly compete on price alone as more processors enter commodity bulk segments, so the companies protecting margin monetize the safety and clean-label layer: DGL-extraction tooling, organic-certification integration, and long-term formulator supply agreements. The four levers below reflect where MMA's interviews with formulator-brand procurement buyers show real, sustained willingness to pay a premium.

DGL Extraction Tooling and Safety Validation Support

Processors increasingly fund dedicated DGL-extraction tooling and safety-profile validation testing, since supplement brands increasingly require documented glycyrrhizin-removal evidence before approving next-generation formulation specifications. Suppliers investing in rigorous safety-validation capability capture meaningfully higher brand-contract win rates than suppliers relying on legacy standard-grade architecture alone, worth roughly 27% higher brand-contract win rates versus conventional standard-grade packages, since extraction investment builds brand trust that marketing claims cannot replicate on their own. Adoption of dedicated safety-validation teams continues accelerating industry-wide as DGL competition expands steadily across every major affected program each cycle, and brands now expect this evidence upfront.
Market Impact: Adds roughly 27 percent higher brand contract win rate

Organic Certification Integration and Clean Label Support

Processors increasingly bundle clean-label validation alongside organic-certified hardware sales rather than selling standard-grade extract as a standalone transaction, since confectionery brands increasingly require documented pesticide-free evidence before committing to formulation contracts. Suppliers offering integrated clean-label-validation services capture meaningfully higher category retention rates than standard-grade-only competitors, worth roughly 21% higher contract-renewal rates within the first three formulation cycles, since validation investment builds brand confidence that standard-grade sales alone cannot replicate. This service revenue stream continues expanding as more brands adopt organic-certified architecture, and smaller processors struggle to match this validation depth.
Market Impact: Adds roughly 21 percent higher overall renewal rate

Long-Term Formulator Supply and Certification Agreements

Large botanical processors increasingly sign multi-year formulator supply and joint-certification agreements guaranteeing consistent access to the latest DGL-extraction technology, converting what used to be a series of individual ingredient purchases into predictable recurring revenue worth roughly 19% of a supplier's forward account revenue across the agreement term. Suppliers offering these agreements gain visibility into future production-volume demand that supports continued capacity investment, while formulators gain protection against inconsistent ingredient quality and pricing volatility on units secured under long-term relationships each formulation cycle. Smaller processors without comparable balance sheet strength increasingly struggle to offer similar long-term terms.
Market Impact: Locks in supply revenue for 3 to 5 years

Clinical Research Partnership and Efficacy Data Programs

Processors offering integrated clinical-research partnerships and efficacy-data programs alongside physical ingredient sales capture recurring licensing revenue while simultaneously deepening customer relationships that make competitive displacement more difficult for rivals without comparable research infrastructure available today. For brands pursuing clinical-differentiation strategies, the value proposition is faster claim-substantiation without separate research and ingredient-procurement processes across multiple supplier channels. Early adopters report research-partnership attach rates approaching 15% among first-time DGL customers, growing steadily each year as clinical-differentiation demand expands across the category, and smaller processors without comparable research-platform budgets increasingly struggle to match this attach rate today.
Market Impact: Reaches nearly 15 percent overall partnership attach rate

Who Controls the Margin Pool

CR5 sits at 48%, reflecting a category moderately concentrated among specialty botanical-extract processors evaluated here on annual processed tonnage and formulator-account share combined. MAFCO Worldwide and Shaanxi Sciphar Natural Products lead on category scale, with a meaningful gap separating them from smaller challengers, including Martin Bauer Group and Givaudan, each strong in specific grade segments or geographies rather than universally. Smaller regional processors increasingly struggle to match the DGL-extraction investment larger competitors now commit.
Current activity centers on three dimensions: DGL-extraction tooling and safety-validation capability, organic-certification integration bundling, and long-term formulator supply capability for large confectionery accounts. Processors lacking DGL-extraction capability are increasingly partnering with specialty biotechnology providers rather than losing brand-contract decisions on missing-technology grounds alone across the wider industry this cycle.

Emerging pressure comes from Chinese domestic suppliers, particularly regional root-sourcing manufacturers, expanding aggressively on production scale into mid-tier segments historically dominated by established North American and European processors. If Chinese suppliers continue converting domestic scale into export competitiveness, expect rankings among the next several challengers to shift by 2031, as scale-led entrants displace slower-moving incumbents across mid-tier segments worldwide. Established leaders have limited time to respond before meaningful share shifts occur nationwide.
north-america-licorice-extract-market-company-positioning-matrix-1787374896731

Competitive Moat and Risk Dimensions

MAFCO WORLDWIDE LLC

Moat: Established North American Sourcing Depth

MAFCO Worldwide's decades of installed sourcing relationships spanning nearly every major North American confectionery and pharmaceutical market give it certification-relationship depth and processing scale that narrower regional suppliers cannot easily replicate across a formulator's multi-decade sourcing relationship. That breadth makes MAFCO a default supplier for formulators seeking a single trusted ingredient relationship. Competitors are unlikely to close this gap quickly.
MAFCO WORLDWIDE LLC

Risk: Standard Grade Legacy Transition Exposure

MAFCO's large installed base of legacy standard-grade sourcing leaves it more exposed than newer DGL specialists to formulators evaluating next-generation safety-profile demand against established formulation-refresh timing. Managing this requires balancing legacy-content support against accelerating DGL investment across the full range of programs served. This tension will intensify as DGL adoption expands.
SHAANXI SCIPHAR NATURAL PRODUCTS CO., LTD.

Moat: Established Chinese Root Sourcing Scale

Shaanxi Sciphar's decades of Chinese root-cultivation footprint and extraction-integration experience give it cross-market standardization and volume-scale depth that newer entrants cannot quickly replicate regardless of technical investment committed. That accumulated sourcing depth increasingly functions as a competitive moat for large multinational formulator negotiations specifically. Competitors are unlikely to close this gap quickly.
SHAANXI SCIPHAR NATURAL PRODUCTS CO., LTD.

Risk: North American Regulatory Compliance Exposure

Shaanxi Sciphar's China-centered production leaves it more exposed than North American processors to import-compliance and traceability requirements that increasingly favor domestically sourced ingredients across sensitive pharmaceutical and supplement programs. Closing this gap requires sustained investment in regulatory-documentation infrastructure over several years. Momentum currently favors domestic rivals in the most compliance-sensitive tenders.

Players Tracked

Prominent Players

MAFCO Worldwide LLC
Shaanxi Sciphar Natural Products Co., Ltd.
Martin Bauer Group
Givaudan SA
Kerry Group plc

Other Key Players

Xi'an Sost Biological Technology Co., Ltd.
Ransom Naturals Ltd.
Indena S.p.A.
Euromed S.A.
Naturalin Bio-Resources Co., Ltd.
Xi'an Realin Biotechnology Co., Ltd.
Hunan Nutramax Inc.
Xi'an Lyphar Biotech Co., Ltd.
Shaanxi Fuheng (FH) Biotechnology Co., Ltd.
AS Harrison & Crosfield
Alland & Robert
Nexira SAS
Synthite Industries Ltd.
Layn Corp
Nutra Green Biotechnology Co., Ltd.

Recent Developments

FEBRUARY 2025

MAFCO Worldwide Expands Organic Certified Licorice Extract Manufacturing Capacity

MAFCO Worldwide announced an organic expansion of its organic-certified licorice extract manufacturing capacity, targeting broader clean-label-validated production volume across additional confectionery and supplement programs ahead of tightening delivery schedules. The expansion follows growing brand demand for validated organic supply nationwide, with additional capacity planned across subsequent phases.
Signal: Signals MAFCO prioritizing organic-certification capacity depth ahead of continued reliance on legacy standard-grade volume alone nationwide.
SEPTEMBER 2024

Martin Bauer Group Signs Long-Term Supply Agreement With North American Confectionery Manufacturer

Martin Bauer Group signed a long-term licorice extract supply agreement with a major North American confectionery manufacturer, securing preferred-vendor status ahead of the manufacturer's expanding clean-label targets. The agreement covers qualification support and capacity planning across the manufacturer's growing delivery schedule this year and well beyond it.
Signal: Signals established suppliers actively pursuing long-term formulator content security ahead of continued clean-label-driven growth across the industry.
APRIL 2025

Shaanxi Sciphar Acquires DGL Extraction Technology Startup

Shaanxi Sciphar Natural Products completed the acquisition of a specialty DGL-extraction technology startup, combining its manufacturing scale with the acquired firm's proprietary selective-extraction technology to expand its health-focused portfolio ahead of tightening supplement-safety demands. The deal closed following standard regulatory review procedures completed earlier this year.
Signal: Signals larger processors actively pursuing extraction-technology acquisition ahead of continued safety-driven demand expanding steadily across the industry.

Raw Root and Extraction Input Costs

Raw licorice root and extraction inputs together account for roughly 46% of ingredient manufacturing cost of goods sold, making these inputs the dominant cost driver in the category ahead of general processing and packaging content. Costs vary by processing-grade requirement, with DGL-extraction formulations driving most of the remaining cost variability processors face across most producing regions today.
Raw licorice root costs spiked sharply through 2021 and 2022 as broader agricultural and pharmaceutical-ingredient demand absorbed available cultivation capacity faster than new capacity could be added, according to company disclosures citing constrained raw-material supply and trade-tariff policy shifts across multiple regional suppliers. Processors without long-term root-supply agreements or in-house sourcing capability saw costs rise faster than they could pass through to fixed-price formulator contracts signed before the spike occurred across the industry.

Smaller regional processors without established root-supply relationships absorb input cost volatility directly into thin margins, while larger players like MAFCO Worldwide and Shaanxi Sciphar use existing material-supply-chain relationships to insulate margins from commodity cost swings across their networks. Suppliers newly entering the category without comparable supply relationships carry meaningfully greater cost exposure than incumbents who capture more of the value chain across the category.
north-america-licorice-extract-market-cost-volatility-analysis-1787374896929

Long-Term Root Supply Agreements

The largest processors are locking multi-year licorice-root supply agreements directly with regional growers rather than competing for spot market capacity, securing priority access and more predictable pricing across major ingredient programs and forecast cycles ahead, reinforcing the scale advantages already present across the category. Smaller processors increasingly struggle to secure comparable terms each cycle.

Vertical Integration Into Root Cultivation

Larger suppliers are investing directly in in-house root-cultivation and cooperative-partnership sourcing capability rather than relying entirely on third-party intermediaries, capturing more of the value chain and reducing exposure to specialty sourcing price swings across the category's highest-volume DGL product lines. This trend continues strengthening as demand for validated formats keeps expanding across every major regional market tracked today.

Component Sourcing Diversification Strategies

Processors are diversifying root sourcing across multiple regional cooperative networks rather than depending on a single source, reducing exposure to specific harvest disruptions that have affected particular production regions during recent volatility episodes across markets. This diversification has become standard practice among the category's larger processors over the past several procurement cycles industry-wide overall each year.

Portfolio Architecture for Margin Defence

MMA's tier architecture separates the category into three margin bands. Volume and commodity-adjacent standard-grade extract competes on price against widely available generic configurations and carries thin margin, premium and certified root-powder and purified-glycyrrhizin platforms carry higher margin on documented purity and safety-profile validation, and sustainability-linked next-generation formats, including DGL and organic-certified systems, command the highest margin as the newest, most differentiated tier available today.
The tension between volume and premium plays out most visibly among mid-sized regional processors, who want DGL depth at closer to standard-grade pricing. That up-tier migration remains slow given how many mid-sized processors still evaluate extraction-tooling budget cost cautiously before committing further capital resources. Suppliers that fail to bundle DGL capability and safety-validation support risk losing share to more capable rivals. Momentum continues building steadily across the industry.

High-value margin pools concentrate in large formulator and brand-partner account agreements bundled with safety-validation, organic-certification-integration, and research-partnership services, where recurring qualification and support-attach revenue increasingly outweighs the margin earned on any individual unit sale alone. That concentration is pulling investment steadily toward DGL and organic-certified capability rather than incremental standard-grade production expansion alone across the category.

Volume / Commodity-Adjacent Tier

Standard-grade licorice extract sold primarily on price against widely available generic configurations, serving cost-sensitive regional formulators where gross margin stays thin and competition is driven almost entirely by kilogram price.
Gross Margin: 10%-16%

Premium / Certified Tier

Root powder and purified glycyrrhizin platforms specified by brands requiring documented purity validation, safety-profile support, and quality agreements, commanding meaningfully higher margin on demonstrated performance achieved across every major transaction market worldwide today.
Gross Margin: 19%-27%

Sustainability / Regulatory / Next-Generation Tier

DGL and organic-certified systems positioned for brands chasing safety commitments and clean-label-validation compliance, where technology innovation and validation depth support the category's highest margin overall across most major markets today.
Gross Margin: 27%-35%
north-america-licorice-extract-market-portfolio-architecture-1787374897435

High-value Sub-segments and Strategic Watch-out

Organic Certified Licorice Extract

The fastest-growing and highest-certification-intensity segment, where brand demand is pulling capital toward validated clean-label content away from legacy conventional-sourcing hardware alone, representing the clearest near-term path to share gain and margin expansion together across a supplier's entire brand relationship base worldwide. Investment here compounds fastest of any category.

Deglycyrrhizinated Licorice (DGL) Extract

Steady, safety-driven growth from processed formats that bundle into large supplement-brand account agreements, less explosive than organic demand but increasingly sticky, giving suppliers reliable recurring revenue tied to formulation-refresh renewal cycles rather than open transaction competition alone across most accounts. Capital cycles drive most of this growth.

Standard Glycyrrhizin-Containing Licorice Extract

The volume core of the category across established processors, sold in steady but modest unit numbers as overall confectionery demand continues growing, competing on price and least affected by the DGL-driven dynamics seen elsewhere in the broader portfolio described above, served across most regions today.

Licorice Flavor Extract

A strategic watch-out segment where growth trails the category average as adoption remains concentrated among legacy niche tobacco-flavoring platforms, and suppliers risk ceding the niche entirely if larger competitors keep deprioritizing standalone investment ahead of clearer DGL and organic-certified demand arriving soon across every affected market.

Formulation Cycle and Brand Certification Economics

An ingredient sale is rarely a single transaction for the largest formulator and brand-partner accounts. Safety-validation, organic-certification-integration, and research-partnership services convert what used to be a one-time purchase into a relationship of recurring formulation volume and qualification-renewal cycles. Suppliers that capture the safety-validation and organic-certification attachment at first sale retain greater lifetime value per account than those competing on kilogram price alone.
Adoption depth varies sharply by brand type. Large global confectionery conglomerates and premium supplement networks convert fastest and most completely, standardizing entire product lines onto DGL or organic-certified architecture once qualification and validation standards align, making them the highest-value account type despite competitive pricing negotiated across the relationship. Smaller regional brands convert more slowly, often relying on legacy standard-grade content for years before adopting DGL or organic-certified formats directly.

A generational shift in formulation buyers is compounding the DGL-driven shift. Younger formulation scientists entering procurement roles increasingly expect validated, data-backed safety-profile platforms as standard specification protocol, a preference an older generation of buyers, trained primarily on cost-first sourcing, rarely weighted as heavily. That shift is accelerating premium-tier adoption even among brands that have not yet faced direct pressure to convert away from legacy standard-grade architecture.
north-america-licorice-extract-market-end-use-penetration-index-1787374897942

What Matters Most Through 2036

These are among the four positions where our research anticipates prominent divergence between winners and laggards over the coming forecast period. Each is grounded in the demand model, the regulatory perimeter, and the announced capacity pipeline.
01 / DGL EXTRACTION CAPACITY INVESTMENT

Build validated safety-profile capacity before competitors do

DGL-extract demand is converting sourcing specification from a niche capability into a mainstream brand expectation, and suppliers with established validated safety-profile data are already capturing disproportionate share of brand-contract decisions ahead of broader market adoption. Suppliers that invest in DGL-extraction capacity now will secure preferred-vendor status with major brand accounts before competitors catch up on the tooling investment required. Continuing to treat capacity as a future concern risks ceding the fastest-growing, most differentiated segment to suppliers already building validated safety-profile depth.
02 / ORGANIC CERTIFICATION PROGRAM DEPTH

Deepen clean label sourcing capability ahead of formulation refresh

Formulator demand increasingly decides sourcing-content selection as much as kilogram cost itself, and suppliers that deepen validated organic-certified pathways will capture disproportionate share of installed brand retention as formulators seek clean-label confidence without full sourcing replacement. Suppliers that invest in open, validated organic technology now will build switching costs that protect installed base better than competitors relying on price alone. This technology investment requires sustained development spending across multiple years before any single formulation-refresh cycle fully rewards that account positioning choice.
03 / RECURRING RESEARCH REVENUE

Bundle validation and research partnership into every large quote

Extended safety-validation bundling and research-partnership services already generate meaningfully higher recurring revenue than standard ingredient sales, yet many suppliers still sell these as separate negotiations rather than a default part of every quote presented to large brand accounts. Suppliers that make validation and research attachment the default, requiring buyers to actively opt out rather than opt in, will capture materially more lifetime value per account than competitors treating these services as an afterthought. This remains underexploited by every supplier outside the two largest players active in the category.
04 / CHINESE SUPPLIER COMPETITION

Diversify toward certified segments ahead of continued direct-trade pressure

Chinese domestic root-sourcing suppliers continue expanding aggressively into mid-tier segments, and processors overly dependent on undifferentiated legacy sales into scale-sensitive markets face real margin compression risk across the forecast period covered in this report. Suppliers that diversify toward certified, differentiated evidence and service sales in segments less exposed to direct-trade competition will protect margin better than competitors continuing to compete primarily on undifferentiated commodity-grade transaction price. This repositioning requires sustained investment in evidence well before competitive pressure fully materializes in each affected market.

Engagement Snapshot From the Field

A live engagement with an industry participant carrying material or product regulatory and market exposure ahead of a defining policy shift, showing how our research translates into a defensible multi-year portfolio strategy.
MARKET MINDS ADVISORY · CLIENT ENGAGEMENT SUMMARY
North America Licorice Extract Producer Strategic Portfolio Review and Transition Roadmap 2026·Investment Scenario on North America Licorice Extract Exposure Evaluation 2025-26
CLIENT PROFILE
The client is a multinational confectionery and supplement manufacturer operating across 5 formulation facilities, with an accelerating DGL-extraction conversion pipeline and a stated goal of standardizing safety-validated content across its retail accounts. Annual R and D and sourcing spend exceeds $52 million (client-reported, unverified by MMA), concentrated primarily across legacy standard-grade, mid-tier root-powder, and emerging DGL product lines across its programs.
STRATEGIC CHALLENGE
The client faced a sourcing-content transition decision balancing DGL-extraction investment against existing standard-grade infrastructure and uncertain formulator-adoption timing across its varied program portfolio. Leadership needed a structured evaluation framework weighing safety benefits against extraction-conversion complexity across its program footprint and budget. Company leadership also worried that a rushed rollout could compromise ongoing supply-chain consistency.
MMA APPROACH
MMA conducted a structured evaluation of the client's current sourcing-content specification patterns against DGL-supplier readiness and validation data across its programs, benchmarked conversion claims against MMA's proprietary specialty-ingredient performance database, and facilitated reference site visits with comparable brands that had already completed DGL conversion. The engagement combined primary interviews with sourcing leadership alongside independent performance verification.
KEY FINDINGS
  1. Two of the client's five formulation facilities lacked reliable regional root-sourcing access capable of supporting full product-line conversion without import cost increases first and foremost.
  2. The client's DGL programs showed meaningfully improved safety-profile outcomes compared with legacy standard-grade sourcing tested across multiple production deployments spanning two separate product categories overall.
  3. Standardizing on validated DGL platforms reduced projected glycyrrhizin-labeling liability incidents by an estimated 14%, per MMA's proprietary internal forecasting model, improving overall program transparency.
  4. Program-specific root-sourcing variation across the client's portfolio emerged as a meaningfully underestimated factor in conversion planning requiring further review ahead of the global rollout scheduled for subsequent phases.
CLIENT PROFILE
The client is a multinational confectionery and supplement manufacturer operating across 5 formulation facilities, with an accelerating DGL-extraction conversion pipeline and a stated goal of standardizing safety-validated content across its retail accounts. Annual R and D and sourcing spend exceeds $52 million (client-reported, unverified by MMA), concentrated primarily across legacy standard-grade, mid-tier root-powder, and emerging DGL product lines across its programs.
STRATEGIC CHALLENGE
The client faced a sourcing-content transition decision balancing DGL-extraction investment against existing standard-grade infrastructure and uncertain formulator-adoption timing across its varied program portfolio. Leadership needed a structured evaluation framework weighing safety benefits against extraction-conversion complexity across its program footprint and budget. Company leadership also worried that a rushed rollout could compromise ongoing supply-chain consistency.
MMA APPROACH
MMA conducted a structured evaluation of the client's current sourcing-content specification patterns against DGL-supplier readiness and validation data across its programs, benchmarked conversion claims against MMA's proprietary specialty-ingredient performance database, and facilitated reference site visits with comparable brands that had already completed DGL conversion. The engagement combined primary interviews with sourcing leadership alongside independent performance verification.
KEY FINDINGS
  1. Two of the client's five formulation facilities lacked reliable regional root-sourcing access capable of supporting full product-line conversion without import cost increases first and foremost.
  2. The client's DGL programs showed meaningfully improved safety-profile outcomes compared with legacy standard-grade sourcing tested across multiple production deployments spanning two separate product categories overall.
  3. Standardizing on validated DGL platforms reduced projected glycyrrhizin-labeling liability incidents by an estimated 14%, per MMA's proprietary internal forecasting model, improving overall program transparency.
  4. Program-specific root-sourcing variation across the client's portfolio emerged as a meaningfully underestimated factor in conversion planning requiring further review ahead of the global rollout scheduled for subsequent phases.
RECOMMENDED STRATEGY
Phase 1: Phase 1 (Months 1 to 5): Complete facility-level root-sourcing assessment and convert the three best-positioned facilities to DGL sourcing first, ahead of the global timeline. Phase 2: Phase 2 (Months 6 to 12): Secure alternative root-sourcing solutions for remaining facilities while closely tracking safety-profile outcomes against baseline metrics. Phase 3: Phase 3 (Months 13 to 19): Complete global product-line standardization pending validated results from the initial deployment phase across all programs.
OUTCOME
The client's first three formulation facilities achieved measurable improvements in safety-profile outcomes and program transparency within eight months of DGL conversion (client-reported, unverified by MMA), supporting the phased global rollout that had originally motivated the supplier-readiness assessment engagement. The remaining two facilities are scheduled for phased conversion over the following ten months.

Frequently Asked Questions

Foundational context covering the market sizes, CAGR, scope, country, region and competition that inform every finding below. This section is provided to cover basics and most often pre-purchase conversations, answered from the MMA Primary Research Dataset.

What is the current size of the North America Licorice Extract Market?

MMA estimates the global licorice extract market at $1.1 billion in 2025, with North America representing its largest single regional segment. Growth concentrates in DGL and organic-certified formats steadily.

How large will the North America Licorice Extract Market be by 2036?

MMA forecasts the market reaching $1.96 billion by 2036, up from $1.16 billion in 2026. That represents roughly a 1.69 times expansion over the full ten-year forecast period covered here.

What is the CAGR for the North America Licorice Extract Market 2026 to 2036?

MMA's base case forecasts a 5.4% compound annual growth rate, with a bull case of 6.6% and a bear case of 4.2% depending on root-harvest volatility trends.

Which segment is growing fastest?

Organic certified licorice extract leads at a 12.4% CAGR, roughly 2.30 times the overall market rate, as brands convert legacy standard-grade content toward clean-label architecture nationwide.

Who are the major companies in the North America Licorice Extract Market?

MAFCO Worldwide, Shaanxi Sciphar, Martin Bauer Group, Givaudan, and Kerry Group lead the category, together holding an estimated 48% combined share on a processed-tonnage basis worldwide. Each maintains distinct sourcing strengths.

Which country is growing fastest?

India leads at an estimated 9.2% CAGR, outpacing the global average as its expanding Ayurvedic and pharmaceutical pipeline and rising domestic botanical-processing investment continue growing faster than any comparable economy.

Report Segmentation Architecture

The full report scope spans multiple orthogonal segmentation dimensions, with cross-tabulated demand data provided for each dimension pair. Coverage extends further to regional breakdowns, trend trajectories, and the competitive detail needed to support segment-level decision-making.

By Processing Grade and Formulation Type

  • Deglycyrrhizinated Licorice (DGL) Extract
  • Standard Glycyrrhizin-Containing Licorice Extract
  • Licorice Root Powder
  • Purified Glycyrrhizic Acid and Glycyrrhizin
  • Licorice Flavor Extract
  • Organic Certified Licorice Extract

By End-Use Industry

  • Confectionery
  • Pharmaceutical and Dietary Supplements
  • Flavor and Beverage
  • Tobacco Flavoring

By Commercial Dimension

  • Branded Formulator Supply
  • Contract Processing Supply
  • Long-Term Formulator Contracts
  • Clinical Research Partnership Services

By Region

  • North America
  • Western Europe
  • East Asia
  • South Asia and Pacific
  • Latin America
  • Middle East and Africa
  • Eastern Europe

Scope, Methodology, and Coverage

Every figure in this report is reproducible from documented input assumptions. The scope below maps the historical period, the forecast horizon, the segmentation dimensions, and the countries covered, alongside the underlying primary and qualitative methodology.
Historical Period
2020 to 2025
Forecast Period
2026 to 2036
Base Year
2025 (USD billions; MMA Primary Research Dataset, August 2026)
Market Definition
The North America licorice extract market covers deglycyrrhizinated licorice extract, standard glycyrrhizin-containing licorice extract, licorice root powder, purified glycyrrhizic acid and glycyrrhizin, licorice flavor extract, and organic certified licorice extract sold to confectionery manufacturers, pharmaceutical and supplement formulators, and flavor and beverage producers across the United States and Canada. It excludes finished licorice candy products sold directly to consumers, unrelated botanical extracts sold as separate ingredient categories, and pharmaceutical drug products requiring separate regulatory approval pathways.
Quantitative Units
USD billions (current prices); processed volume in metric tons where applicable
Segmentation Dimensions
By Processing Grade and Formulation Type; By End-Use Industry; By Commercial Dimension; By Region
Regions Covered
North America, Western Europe, East Asia, South Asia and Pacific, Latin America, Middle East and Africa, Eastern Europe
Countries Covered
USA, Canada, China, Iran, Germany, Netherlands, UK, France, Japan, South Korea, India, Australia, Brazil, Mexico, Indonesia, Vietnam, Thailand, UAE, Saudi Arabia, South Africa, Turkey, Poland, Italy, Spain, Sweden, Switzerland, Argentina, Colombia, Afghanistan, Uzbekistan, and additional markets relevant to this sector
Key Companies Profiled
MAFCO Worldwide LLC, Shaanxi Sciphar Natural Products Co., Ltd., Martin Bauer Group, Givaudan SA, Kerry Group plc, Xi'an Sost Biological Technology Co., Ltd., Ransom Naturals Ltd., Indena S.p.A., Euromed S.A., Naturalin Bio-Resources Co., Ltd., Xi'an Realin Biotechnology Co., Ltd., Hunan Nutramax Inc., Xi'an Lyphar Biotech Co., Ltd., Shaanxi Fuheng (FH) Biotechnology Co., Ltd., AS Harrison & Crosfield, Alland & Robert, Nexira SAS, Synthite Industries Ltd., Layn Corp, Nutra Green Biotechnology Co., Ltd.
Quantitative Methodology
Primary survey, n=3,800 respondents, Q4 2025, six countries; demand-side model with trade association cross-validation
Qualitative Methodology
47 expert interviews, Q4 2025; applied to validate demand model assumptions, identify emerging dynamics, and assess competitive positioning
Report Format
PDF and XLSX data workbook (Word format preview document)
Publisher
Market Minds Advisory
Report Code
MMA-2026-CHM-103
Published
August 2026
Contact
sales@marketmindsadvisory.com | www.marketmindsadvisory.com

Purchase the full North America Licorice Extract Market Report (2026 to 2036).

The full North America Licorice Extract Market report delivers granular five-year and ten-year forecasts across all six processing-grade segments, adoption tracking by region, and supplier benchmarking drawn from MMA's proprietary specialty-ingredient database. It includes detailed profiles of all twenty companies covered here, extended regional analysis across every major producing market worldwide, and a technology tracker spanning DGL-extraction and organic-certification platform development. Subscribers receive quarterly data refreshes through the full forecast period. Buyers also gain direct analyst access for engagement-specific questions throughout the subscription term, including scheduled quarterly briefing calls with the practice lead.
DGL extraction adoption and safety tracker
Ten-year segment-level forecasts across all grade types
Supplier benchmarking data across pricing and certification
Technology platform development tracking module here
Twenty-company competitive profiles with moat analysis
Quarterly data refresh access throughout subscription period

Built For The People Who Decide

From boardroom strategy to bench-side execution, this report is read cover-to-cover by leaders shaping the next decade of their industry, turning demand scenarios, market dynamics and valuation benchmarks into decisions.
CXOs/ Presidents/ VPs/ Managers
M&A and Corporate Development
Strategy Teams and R&D Heads
Procurement and Product Directors
Regulatory and Compliance Leaders
Investor Relations and Equity Analysts